HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Clinical trials for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug NT-88 aims to improve heart function in early trial
Disease control Not yet recruitingThis study tests a new drug called NT-88 (Zuozhu Daxi) in 60 adults with heart failure where the heart's pumping ability is mildly reduced. Participants will receive either standard heart failure drugs or standard drugs plus NT-88. The goal is to check safety and see if NT-88 can…
Matched conditions: HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Guangzhou Manjing biomedicine technology co., ltd • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can quick drug optimization after heart failure hospitalization save lives in women?
Disease control Not yet recruitingThis study tests whether quickly starting and increasing guideline-recommended heart failure medications after hospitalization improves outcomes in women. About 360 women from 13 Italian hospitals will be randomly assigned to either a high-intensity care group (rapid drug optimiz…
Matched conditions: HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Phase: PHASE4 • Sponsor: IRCCS Policlinico S. Donato • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC